PillBenztropine Mesylate
Benztropine Mesylate
1 active makers
soon
soon
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi USA, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jan 27, 2026RESOLVEDShortage resolved: Benztropine Mesylate Injection (Fresenius Kabi USA, LLC)
Benztropine Mesylate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Neurology.
- Jan 27, 2026SHORTAGEDrug shortage: Benztropine Mesylate Injection (Fresenius Kabi USA, LLC)
Benztropine Mesylate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Neurology.
- Jul 1, 2013RECALLRecall (Class II): Benztropine Mesylate Injection, USP, 2 mg/2 mL (1 mg/1 mL), 2 mL Single Dose Vial, Rx only, labeled as a) Manufactured …
Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination observed in reserve sample vials — Recalling firm: Fresenius Kabi USA, LLC — Nationwide & Puerto Rico